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Abstract: The emerging field of nanomedicine provides new approaches for the diagnosis and
treatment of diseases, for symptom relief and for monitoring of disease progression. One route of
realizing this approach is through carefully constructed nanoparticles. Due to the small size inherent
to the nanoparticles a proper characterization is not trivial. This review highlights the application of
time-resolved fluorescence spectroscopy and fluorescence lifetime imaging microscopy (FLIM) for the
analysis of nanoparticles, covering aspects ranging from molecular properties to particle detection
in tissue samples. The latter technique is particularly important as FLIM allows for distinguishing
of target molecules from the autofluorescent background and, due to the environmental sensitivity
of the fluorescence lifetime, also offers insights into the local environment of the nanoparticle or its
interactions with other biomolecules. Thus, these techniques offer highly suitable tools in the fields
of particle development, such as organic chemistry, and in the fields of particle application, such as in
experimental dermatology or pharmaceutical research.
Keywords: nanomedicine; dendritic nanoparticles; time-resolved fluorescence depolarization;
fluorescence lifetime imaging microscopy; FLIM
1. Introduction
1.1. Time-Resolved Fluorescence Spectroscopy and Imaging in Relation to Nanomedicine and Pharmaceutics
The field of nanomedicine encompasses the application of nanomaterials and devices as
therapeutic or diagnostic tools in medicine with the aim of improving the diagnosis, prevention
and treatment of diseases for a better understanding of the complex underlying pathophysiology of
diseases, and for improving the quality of life of patients [1]. Nanoparticles are often defined as those
having a size smaller than 100 nm. As a consequence of the availability of many different building
blocks and the almost limitless possibilities in manipulating particle size, shape, and surface chemistry
a wide range of nanoparticles has been developed [2]. However, small changes to the physicochemical
properties of a nanoparticle can have a significant impact on their bioreactivity and therefore particles
will need to be assessed on a case-by-case basis [2]. To fully exploit the potential of nanoparticles for
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nanomedical applications a clear understanding of both physicochemical and physiological processes
is mandatory as these provide the underlying basis for the way nanoparticles interact with their
microenvironment [3].
Time-resolved fluorescence spectroscopy and imaging have been successfully used in elucidating
structure and function of biological samples, e.g., proteins [4], and also have the potential to
provide an extremely powerful set of tools in the evaluation of dye-conjugated polymeric materials,
nanoparticles, and nanocapsules [5,6]. However, in the study of nanoparticles time-resolved
fluorescence measurements have not been used as much as steady-state approaches, such as the
analysis of fluorescence emission spectra and steady-state anisotropy, even though they offer the
possibility for a deeper understanding of the nanoparticle itself and the local environment as well as
being able to provide information on loaded drug molecules.
Time-resolved recordings of the fluorescence emission, i.e., the fluorescence lifetime curves, are
highly sensitive to a fluorophores environment and the respective fluorescence decay curves can thus
be used to gain insights into dye-nanoparticle conjugate systems, such as the validation of conjugation,
the interaction of nanoparticles with their environment, but also into the distribution and environment
of guest molecules within nanoparticles. Furthermore, time-resolved measurements of the fluorescence
depolarization, i.e., the fluorescence anisotropy, can be used to determine the size of nanoparticles
and in addition they also contain information on the conformational flexibility of the nanoparticle
structure and on the conformational space of loaded guest molecules. Recording the time-resolved
fluorescence emission in a spatially resolved fashion on samples under a microscope, i.e., fluorescence
lifetime imaging microscopy (FLIM), can provide localized information on fluorophores in cell and
tissue samples. The use of FLIM includes environmental sensing of, amongst others, polarity, local pH,
oxygen and calcium concentrations, as well as the study of biomolecular interactions in living cells
(e.g., [7–9]). There is a large variety of different fluorescent probes available, also in nanoparticulate
form, that are widely used in fluorescent imaging (for a review see [10]). New developments in the
analysis of fluorescence lifetime imaging microscopy data enable fast and reliable localization of target
molecules, e.g., dye-nanoparticle conjugates, despite an autofluorescent background, thus allowing for
the detection of fluorescently labeled nanoparticles in cellular systems and tissue samples [11–16].
1.2. Dendritic Nanoparticles
In the field of nanomedicine the vast diversity of nanoparticles ranges from hard inorganic and
metallic nanoparticles to soft nature-derived or synthetic polymer-based nanoparticles [1,3,6,17–19].
Within this spectrum one can find dendritic polymer-based nanoparticles, in the following termed as
dendritic nanoparticles. This review will highlight how time-resolved fluorescence spectroscopy and
imaging can be used to gain insights into diverse molecular properties of dendritic nanoparticles and
show how these techniques were used to investigate the mode of action of dendritic nanoparticles.
For a better understanding, the nanoparticle systems serving as model systems in the context of
this review will be introduced in the following. Among polymeric nanoparticles there are two major
classes: plain nanoparticles made from aggregating individual polymeric molecules and dendritic
nanoparticles, which are based on a branched focal point surrounded by covalently-attached molecules.
Nanoparticles which are based on the aggregation of individual polymeric molecules are only stable
at concentrations above the critical aggregation concentration, and are unstable in high dilution, i.e.,
they disassemble at low concentrations. In contrast to that, dendritic nanoparticles are unimolecular
nanoparticles, and they are stable even under high dilution [20]. Further benefits of dendritic over
plain nanoparticles are their good solubility in different solvents, their well-defined structure, and
the large number of functional groups at the surface which can be used for further modifications.
The combination of these features makes dendritic molecules interesting for a broad spectrum of
applications, e.g., as multifunctional polymeric support in catalysis, as a template for the synthesis of
inorganic nanoparticles, as environmentally sensitive dendritic fluorescent or phosphorescent probes,
amongst others for oxygen imaging [21], and even for energy harvesting and storage [22]. Nevertheless,
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the dominant field of application of dendritic molecules is the delivery of agents, namely the delivery
of drugs, dyes, contrast agents, and even genes [20,23]. As the synthesis of dendritic molecules is often
based on a modular approach, the needs for different applications can be met by the introduction
of tailor-made building blocks. This allows for example the rational design of nanoparticles for the
delivery of specific drugs, and an optimal solubility and mode of action in the intended medium.
The so-called core building block with its dendritic, i.e., tree-like architecture offers voids in their
interior, which are exploited as cavities for the entrapment of guest molecules. These features enable
dendritic nanoparticles for both the use in therapeutic as well as diagnostic applications [24,25].
A representative of dendritic nanoparticles is dendritic polyglycerol sulfate (dPGS). This molecule
is characterized by a highly ordered, branched architecture, a globular shape and negatively charged
sulfate groups at the surface, leading to an overall biocompatible nanoparticle (Figure 1A) [26–28].
dPGS has been demonstrated to be bioactive [26] and has been used as a biomarker [25,29]. The
anti-inflammatory activity has been shown to be mediated by the binding of dPGS to selectins [26,30].
This behavior was found to be specific for dPGS and was not found for other polyanions [31]. A recent
study identified a complex structure-activity relationship, implying that multivalency, particle size, as
well as the structural flexibility all define and modulate the biological activity of dPGS [32,33].
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Figure 1. Dendritic polyglycerol sulfate and core-multishell nanocarrier architecture. (A) Schematic 
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permission of The American Chemical Society © 2012). 
dPGS is based on dendritic polyglycerol (dPG), depicted in black in Figure 1A. Instead of 
modifying the surface of the nanoparticle with sulfate groups as in dPGS, dPG can as well be used as 
a branching scaffold in the synthesis of the so-called core multishell (CMS) nanocarrier. In that case 
amphiphilic water-soluble linear molecules serving as a double shell are attached to the large amount 
of functional groups of dPG, leading to a liposome-like particle with different polarities of the 
segments (Figure 1B): the polar dPG core, surrounded by a nonpolar alkyl chain as the inner shell 
and a hydrophilic methyl ether PEG (mPEG) as the outer shell (Figure 1B) [35,36]. These nanoparticles 
have been shown to be good carriers for hydrophobic, poorly water-soluble drugs [35,37]. 
Furthermore, CMS nanocarriers have been shown to target tumor tissue [27] and have been studied 
for the delivery of anti-inflammatory drugs and pain killers [38]. Recently published studies 
demonstrate the biocompatibility of these CMS nanocarriers, tested on in vitro and in vivo skin 
disease models [39,40]. 
The transport of drugs can be accomplished by either covalent attachment of the drug to the 
carrier or by the physical entrapment of the drug inside the carrier or carrier aggregates, generally 
referred to as encapsulation [34]. The field of dendritic nanoparticles has developed a large span of 
particles differing in their intrinsic material properties and particle sizes. Based on the library of 
various materials and building blocks, tailor made particles with features like targeting moieties, on-
demand release or cleavage of a drug, and degradation of the particle can be realized [20,41]. As an 
example, pH-responsive dendritic core-multishell nanocarriers have been reported, allowing for 
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dPGS is based on dendritic polyglycerol (dPG), depicted in black in Figure 1A. Instead of
modifying the surface of the nanoparticle with sulfate groups as in dPGS, dPG can as well be
used as a branching scaffold in the synthesis of the so-called core multishell (CMS) nanocarrier.
In that case amphiphilic water-soluble linear molecules serving as a double shell are attached to
the large amount of functional groups of dPG, leading to a liposome-like particle with different
polarities of the segments (Figure 1B): the polar dPG core, surrounded by a nonpolar alkyl chain
as the inner shell and a hydrophilic methyl ether PEG (mPEG) as the outer shell (Figure 1B) [35,36].
These nanoparticles have been shown to be good carriers for hydrophobic, poorly water-soluble
drugs [35,37]. Furthermore, CMS nanocarriers have been shown to target tumor tissue [27] and have
been studied for the delivery of anti-inflammatory drugs and pain killers [38]. Recently published
studies demonstrate the biocompatibility of these CMS nanocarriers, tested on in vitro and in vivo
skin disease models [39,40].
The transport of drugs can be accomplished by either covalent attachment of the drug to the
carrier or by the physical entrapment of the drug inside the carrier or carrier aggregates, generally
referred to as encapsulation [34]. The field of dendritic nanoparticles has developed a large span of
particles differing in their intrinsic material properties and particle sizes. Based on the library of various
materials and building blocks, tailor made particles with features like targeting moieties, on-demand
release or cleavage of a drug, and degradation of the particle can be realized [20,41]. As an example,
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pH-responsive dendritic core-multishell nanocarriers have been reported, allowing for cleavage of the
CMS shells from the core at acidic pH thereby leading to more efficient drug release [11].
In this review we highlight the use of time-resolved fluorescence spectroscopy in “cuvette”
experiments to characterize the molecular properties of dendritic nanoparticles, such as size, and
conformational dynamics of the polymer branches, as well as cargo partitioning and biomolecular
interactions by using a classical organic fluorophore as a reporter group. Furthermore, we provide
insight on how the sensitivity of the fluorescence lifetime to the microenvironment can be used in
FLIM experiments to localize these nanoparticles in cells and tissue sections. This review is primarily
intended for pharmaceutical and medical researchers.
2. Basic Concepts of Time-Resolved Fluorescence
Fluorescence occurs upon relaxation of an excited-state electron to the ground state by photon
emission. Molecules with the ability to fluoresce are known as fluorescent dyes, fluorophores
or, as often found in biomedical literature, fluorochromes. Fluorescence spectroscopy and
microscopy have become very useful and powerful tools, not only in modern day biophysics,
but also for high throughput screening in pharmaceutical research [42–45]. From steady-state to
time-resolved fluorescence, from fluorescence emission spectra to state-of-the-art single-molecule
methods, fluorescence measurements have been extensively used to study and visualize localization,
interaction and dynamics of biomolecules (e.g., [4]). In the following, the main aspects of fluorescence
relevant for the application of time-resolved fluorescence spectroscopy and imaging of nanoparticles
in nanomedicine will be discussed. This includes the fluorescence lifetime, an environmental sensitive
parameter which can, for example, report on the distribution of loaded drug molecules, fluorescence
quenching, which can be used to determine molecular interactions, and the fluorescence time-resolved
fluorescence anisotropy, containing information on successful drug binding or incorporation,
on nanoparticle size and conformational flexibility.
2.1. Fluorescence Properties and Lifetime
The main principle of fluorescence emission is often visualized by a Jablonski diagram (Figure 2A).
Absorption of a photon transfers a ground-state electron into the excited state. From here the electron
will return back into the electronic ground state, either by non-radiative processes or by sending out
a photon. The latter is the fluorescence emission. The fluorescence emission spectrum of a fluorophore
characterizes the wavelength dependent emission of a fluorophore at a certain excitation wavelength.
A characteristic of the emission spectrum is the red-shift, i.e., a shift to lower wavelengths, of the
spectrum compared to the absorption spectrum, known as the Stokes-shift (Figure 2B).
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Different fluorophores have different efficiencies for converting absorbed photons into
fluorescence emission. This efficiency is defined by the quantum yield η:
η =
number o f emitted photons
number o f absorbed photons
(1)
The quantum yield is only equal to 1 if every absorbed photon is also emitted. However, this
is hardly ever reached, as other ways to dissipate the energy gained by photon absorption exist.
For example, the quantum yield of fluorescein is 0.79 (in aqueous solution) [46], and the quantum
yield of indocarbocyanine is 0.07 (in methanol) [47].
A further characteristic property of a fluorophore is the fluorescence lifetime. The fluorescence
lifetime τ describes the average time an exited-state electron remains in the exited state before relaxing
to the ground state via photon emission. The fluorescence lifetime is dependent on the rate of photon
emission kr and the rate of the non-radiative decay processes knr (Equation (2)):
τ =
1
kr − knr (2)
The influence of the non-radiative decay rates is also the root of the environmental sensitivity of
the fluorescence lifetime (Figure 3). While the intrinsic radiative decay rate remains unchanged, the
contribution of non-radiative decay processes is strongly dependent on the fluorophores environment.
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(A) Fluorescence decay traces of the fluorescent dye Nile Red (NR) in different environments:
ethanol/water (1:1) mixture, DMSO, and encapsulated within CMS nanocarriers dissolved in aqueous
solution; (B) Fluorescence decay traces of an indocarbocyanine dye (ICC) in different environments:
aqueous solution, ethanol, and covalently attached to the surface of dPGS nanoparticles (dissolved in
aqueous solution).
2.2. Fluorescence Quenching and Energy Transfer Mechanisms
Quenching describes the phenomenon of a reduced quantum yield or lifetime of a fluorophore
through interactions with another molecule. Such molecules are called quenchers. Two types of
quenching can be distinguished: static and dynamic quenching [48,49]. Dynamic quenching is caused
by interactions of the quencher and the fluorophore in the excited state. As the interaction with
a quencher represent a further way of non-radiative return into the ground state the fluorescence decay
is affected. In contrast, static quenching involves the formation of non-fluorescent complexes between
ground-state fluorophores and the quencher and does not affect the fluorescence decay.
Other possible energy transfer mechanisms depopulating the excited state can be classified into
short and long range mechanisms. Short range energy transfer involves the transfer of an electron
between a fluorophore and a quencher. This can occur when the two molecules come into close
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contact and is only effective within distances up to ~1 nm. Several different mechanisms of
electron transfer induced quenching are known, including Dexter mechanism [50] and photo-induced
electron transfer [51]. Long range energy transfer is mediated by dipole-dipole interactions between
two molecules designated as the donor (D) and the acceptor (A) molecule. This long range energy
transfer mechanism is known as Förster resonance energy transfer (FRET) [52].
2.3. Time-Resolved Fluorescence Anisotropy
Brownian motion is the irregular displacement of particles in a gas or liquid resulting from
collisions, induced by thermal agitation, between the particles themselves and the surrounding atoms
or molecules. It leads to both lateral and rotational diffusion of the particles. The rotational diffusion
is dependent on the rotating particle’s size and shape. Assuming a spherical particle the rotational








where R and V are the radius and the volume of the rotating sphere, respectively, η the viscosity of
the solvent, T is the temperature and kB the Boltzmann constant. The dependence of the rotational
diffusion on the size can be exploited to determine the particle size, e.g., in time-resolved fluorescence
polarization or anisotropy experiments. These experimental approaches make use of the fact that the
absorption of electromagnetic radiation occurs due to interactions between the electric vector of the
incoming light and the dipole moment of the fluorophore. Excitation with linearly polarized laser light
thus generates a population of excited fluorophores with a specific orientation of dipole moments, i.e.,
an anisotropic or polarized distribution, within an isotropic distribution of fluorophores.
Rotational diffusion of the excited fluorophores, occurring before the emission of a photon at time
t, leads to a certain amount of depolarization. By measuring the intensity of the emission parallel
(I‖(t)) and perpendicular (I⊥(t)) to the polarization of the excitation light the remaining degree of
polarization at time t can be determined. This can either be expressed as the time-resolved fluorescence










2.4. Measurement of Fluorescence Lifetime—Spectroscopy
The fluorescence lifetime of samples in solution can be determined using a time-correlated single
photon counting (TCSPC) setup [53]. TCSPC describes a detection principle that allows to determine
the time after excitation at which a photon was emitted. In TCSPC measurements the sample is
excited with a short, periodic light pulse, e.g., from a picosecond diode laser, white light laser, or
Titanium-Sapphire laser with repetition rates in the MHz range. Single emitted photons are then
detected. By combining information on the exact time points of the photon detection and the excitation
event of that emitted photon, the time after excitation at which the photon was emitted can be obtained.
All detected photons then contribute to the histogram of the photon emission times. To accurately
reproduce the fluorescence decay curves, sufficient numbers of individual photon recordings are
required and hence the process of sample excitation and single photon detection has to be performed
a large number of times. To prevent artefacts in the measured fluorescence decay curves the likelihood
of having multiple emitted photons per excitation pulse needs to be very small. Therefore, the ratio of
photon counts to excitation pulses has to be kept sufficiently low, varying from 1:100 to 1:200 [49,53,54].
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2.5. Measurement of Fluorescence Lifetime—Microscopy
The principles of measuring fluorescence decay curves with a TCSPC detection system can also
be applied to measure the fluorescence decay curves in a spatially resolved fashion, i.e., for each image
pixel of a microscope image. Therefore, the excitation light from a pulsed laser source is coupled to
a confocal raster scanning microscope [12,15] and single emitted photons are registered by the detector
(e.g., single photon avalanche photodiodes, or hybrid detectors [7,12]).
A confocal raster scanning microscope does not illuminate the whole sample at once, but only
a small portion of the sample, the so called confocal volume. A point illumination source, e.g., a laser,
is used as excitation light source. The confocal excitation volume is generated by the introduction of
a pinhole into the light path. The pinhole is in a conjugated focal plane to the illumination plane within
the sample. The main advantage is the suppression of out-of-focus light by the pinhole, even allowing
for the acquisition of 3D-images, by scanning the illumination beam both laterally and in the z-plane.
To gather information on the whole sample, the confocal volume is moved across the sample, i.e.,
scanned, and a measurement recorded for each spot. This is usually achieved by a pair of mirrors that
can scan the illumination beam across the sample. The whole image can then be reconstructed from
the sequential, individual measurements. In essence, this type of confocal TCPSC- based FLIM adds
the fluorescence lifetime information to a classical confocal laser scanning microscopy experiment.
Two examples of this type of measurement applied to tissue sections will be presented in this review.
Other fluorescence lifetime detection schemes include phase modulation techniques, i.e., using
a sinusoidally modulated continuous wave excitation beam, in combination with a wide-field
microscope, and wide-field time-gated fluorometry, which amongst others is well suited for
phosphorescent probes with lifetimes in the microseconds range [8]. An advantage of FLIM wide-field
microscope techniques is the fast acquisition time, thereby, e.g., reducing light damage in the
measurements of living cells.
Multiphoton FLIM measurements allow for non-invasive imaging because of deeper tissue
penetration due to the excitation in the near-infrared wavelength region. Similarly, endoscopic FLIM
approaches were successfully applied. This allows the imaging, e.g., of human skin physiology and
percutaneous drug penetration, as well as clinical applications [55–58].
3. Molecular Properties of Dendritic Nanoparticles
The molecular basis of nanoparticle interactions with cells and tissue, which is key to the targeted
delivery of drugs, can only be understood with precise knowledge of the molecular properties of the
nanoparticle. Important properties include the size and conformational flexibility of the nanoparticle
but also the loading, distribution, and release of drug molecules.
3.1. Drug Binding and Release from the Nanoparticle (via Time-Resolved Anisotropy)
For biomedical applications it is of great importance to determine if reporter groups have been
bound to the nanoparticle, or if drug molecules have been successfully loaded into the nanoparticle
architecture, and also to study if and when these drug molecules are released. As time-resolved
fluorescence anisotropy measurements reflect on the conformational freedom of loaded or bound
fluorescent molecules, binding of dye conjugates, as well as loading and release of fluorescent drugs
and drug mimetics can be investigated.
The anisotropy decay is commonly described by an exponential decay model function
(Equation (6)), yielding a decay time constant, the so-called rotational correlation time φ:






where r0 is the initial anisotropy at t = 0. While a freely rotating small molecule will usually have
a fluorescence anisotropy that decays to zero on the subnanosecond timescale with only a single
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rotational correlation time, a fluorescent dye bound to a larger macromolecule, e.g., a protein or a
nanocarrier, will usually display a longer, more complex decay behavior of the fluorescence anisotropy
r(t), described by a multiexponential decay model (Equation (7)):






with βi as the amplitude of the ith decay component φi, and r0 the initial anisotropy. The extent
of rotational diffusion of the dye is limited by the surrounding constituents of the macromolecule,
reducing the dye’s motional freedom. Further contributions to the rotational diffusion behavior of
the dye can result from the tumbling motion of the whole molecule but also from the segments of the
macromolecule to which the fluorescent dye is attached. Therefore, the rotational correlation times φi
are a measure of different mobilities (e.g., dye, segment, macromolecule), while the amplitudes βi of
the decay components reflect on the conformational space for the corresponding motion φi. A common
model to describe this restricted rotational diffusion is the “wobbling-in-a-cone” model [59,60]. The
time-resolved fluorescence anisotropy of a fluorescent drug or drug mimetic successfully incorporated
into the nanoparticle architecture is hence expected to display a multiexponential decay behavior.
Time-resolved fluorescence anisotropy measurements were used to study the model drug mimetic
Nile Red loaded into CMS nanocarriers (CMS/NR) [61]. NR was chosen as it hardly fluoresces in
aqueous solution. Hence, all observable fluorescence is from NR loaded into CMS when CMS/NR is
dissolved in an aqueous solution. Loading of NR into hydrophobic parts of CMS nanocarriers was
confirmed by the multiexponential decay behavior of the fluorescence anisotropy for CMS/NR in
aqueous solution (Figure 4B, loaded drug). Further, when measuring the time-resolved fluorescence
anisotropy for CMS/NR in an apolar solvent (DMSO) the observed anisotropy decay (Figure 4B,
released drug) was very similar to NR free in solution (Figure 4B, only drug), indicating nearly free
rotation of NR and hence release of NR into solvent.
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3.2. Nanoparticle Size—Unimer (via Time-Resolved Anisotropy) 
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Figure 4. Se siti it f ti -r s l e fluorescence anisotropy curves r(t) for the conjugation
stat between anocarrier and fluorescent drug ( i ti ). ( ) Sche atic diagram depicting the
depolarization rates of fre an c rri r bound fluorescent dye molecules; (B) Example of
time-resolved fluorescence anisotropy curves r(t) of , free and loaded onto CMS na ocarriers
(CMS/NR). Loaded drug: CMS/NR dissolved in an aqueous solution; released drug: CMS/NR in
DMSO; only drug: NR in DMSO. See [61] for more details on the TCSPC based measurements .
3.2. Nanoparticle Size—Unimer (via Time-Resolved Anisotr py)
Nanoparticles are inher ntly char cterized by their small size. Size det rmination is a routine
procedure for the char cterization of na oparticles. Furthermore, the size of a na oparticle can have
direct implications for its intended use, as size is one of the factors governi g the nano-bio interface.
Methods to determine the size articles include, e.g., lectron microscopy, and dynam c
light scattering. Tim -resolved fluorescence anisotropy measurements also the possibil ty to
det rmine the size of a na oparticle contain g an incorporated fluorescent drug (mi etic) or an
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attached fluorescent reporter group. The advantage of using time-resolved fluorescence spectroscopy
is that the size determination can be performed directly in solution with small sample volumes (e.g.,
50 µL are sufficient when using 3 mm × 3 mm quartz cuvettes) and low sample concentrations (in the
range of 1–5 µM relating to the fluorophore; the required nanoparticle concentration depends on the
respective labeling stoichiometry).
The time-resolved fluorescence anisotropy curve of a nanoparticle with loaded or covalently
attached fluorescent reporter groups usually has a multiexponential decay behavior that allows for
the assignment of the different main decay components to different modes of rotational motion. For
example, the slowest rotational correlation time φG (Figure 5A) of the anisotropy decay curve usually
describes the rotational diffusion of the whole system and therefore contains information on the size of
the particle. The Stokes-Einstein equation (Equation (3)) relates the rotational diffusion coefficient Drot
with the radius r of the rotating sphere. Hence, the rotational diffusion depends on the size and shape
of the molecule as well as on the viscosity of the solvent. The rotational correlation time of the whole
system φG is related to the rotational diffusion coefficient Drot (Equation (8)) by:
φG = (6Drot)
−1 (8)
and thus the apparent volume V of the rotating sphere can be determined from the measured slowest





Conducting fluorescence anisotropy measurements at different temperatures allows to plot φG as
a function of ηkBT (Figure 5B). The volume, and hence the radius, can then be obtained from a linear
fit to the data. For a single temperature the radius can also be directly calculated from the rotational
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Using the information from the slowest rotational correlation time ߶ୋ the size of two dendritic 
polyglycerol-based nanoparticles [15,61] was determined. The size of CMS nanocarrier unimers was 
calculated to 7.2 ± 0.5 nm from the fluorescence anisotropy decay data of loaded NR using the slope 
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Application to a dendritic polyglycerol sulfate (dPGS) with a covalently bound indocarbocyanine dye 
Figure 5. Determining the size of a nanoparticle from fluorescence anisotropy decay curves as measured
by TCSPC. (A) Exemplary anisotropy decay for CMS/NR. The slowest rotational correlation time φG
reflecting the tumbling of the whole nanocarrier is indicated; (B) Plot of φG obtained for CMS/NR
against η/kBT. The volume of the rotating molecule, here CMS, can be obtained from the slope of
a linear fit to the data and hence the diameter and radius can be calculated; (C) Diameters of dPGS-ICC
calculated directly from φG as a function of temperature. A shrinkage in size can clearly be seen.
(A,B, adapted with permission from Boreham et al. [61]. © 2014 The American Chemical Society;
C, adapted from Boreham et al. [15] by permission of John Wiley and Sons © 2014).
i t e i for ation fro the slo est rotational co relation time φG i
l , . i f i i
l . 0.5 fl rescence anisotropy decay data of loaded NR using the slope of
the slowest rotati nal correlation time φG plotted as a function of η/kBT (Figure 5B) [61]. Application to
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a dendritic polyglycerol sulfate (dPGS) with a covalently bound indocarbocyanine dye (ICC) revealed
a shrinking of the polymer structure when increasing the temperature (Figure 5C) [15].
3.3. Drug Partitioning in Nanocarrier (via Fluorescence Lifetime)
The drug partitioning within the nanocarrier architecture can have important consequences for
the drug retention and release behavior. Drugs located too close to the surface may be prone to early
expulsion from the nanocarrier while drug molecules located deep within the nanocarrier architecture
are better protected from expulsion. However, drugs located away from the surface will also require
longer release times at the desired release site. Therefore, an understanding of the drug localization
within the nanocarrier architecture is necessary for optimized drug retention and release. One possible
avenue to investigate the distribution of drug molecules in the nanocarrier architectures is to use
a readout method with a high environmental sensitivity.
The fluorescence lifetime is very sensitive to a fluorophore’s environment. This is mainly due
to the strong influence of the environment on the non-radiative decay rate. For example, polar
environments tend to reduce the fluorescence lifetime as the non-radiative decay rate is increased due
to a higher efficiency of energy transfer to larger dipole moments of the polar environment. Further,
some fluorophores exhibit different fluorescence lifetimes depending on their conformation. Here,
environmental constraints favoring a certain conformation, such as steric hindrance, can be deduced
from the measured fluorescence lifetime [12,15,62].
The fluorescence lifetime τ is obtained from an exponential fit to the recorded fluorescence decay
curve I(t) (Equation (11)):






with I0 the intensity at time t = 0. However, also more complex fluorescence decay curves can occur,
e.g., due to the presence of more than one fluorophore type, the existence of different populations of
the same fluorophore or even just because of the molecular structure of the fluorophore itself. These
fluorescence decay curves can be approximated by a sum of exponentials according to Equation (12):






where αi is the respective relative amplitude of the ith lifetime component τi. Due to the high
environmental sensitivity of the fluorescence lifetime of a fluorophore, analysis of the fluorescence
decay behavior can be used, for example, to determine the distribution of fluorescent drug mimetics in
nanocarrier architectures. Nile Red is often used as a hydrophobic drug mimetic [34]. Naturally one
would assume that a hydrophobic drug should be located in the hydrophobic parts of the nanocarrier.
The following example describes how fluorescence measurements provide information on the rather
complex distribution of the fluorescent drug mimetic within the dendritic nanocarrier.
Based on steady-state fluorescence measurements Fleige et al. [34] had been able to show that NR
resides within the outer shell of CMS nanocarrier. However, time-resolved fluorescence measurements
(fluorescence lifetime measurements) [61] allowed to determine that NR actually partitions into
different regions of the outer shell of CMS nanocarriers (Figure 6). In order to determine the NR
partitioning within the outer shell, the fluorescence lifetimes of NR within the CMS nanotransporter
were compared to the fluorescence lifetimes obtained for NR in different mPEG/water mixtures
(Figure 6A), mimicking the outer shell of the CMS nanocarrier. The results showed that the fluorescence
decay of NR within the CMS nanocarrier contains fluorescence lifetime components found both for NR
molecules located in a water devoid mPEG mixture and in a mPEG/water mixture with a water content
of 70%, suggesting a distribution of NR within the outer mPEG shell of the CMS nanotransporter
(Figure 6B). Furthermore, the distribution of the NR molecules in these two regions could be determined
from the amplitudes of the respective lifetimes, with 78% of NR molecules residing away from the
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surface at 20 ◦C. In addition, by measuring the fluorescence decay of NR in CMS nanocarriers dissolved
in other solvents it was shown that the polarity of the solvent affects the drug distribution in the
outer shell. Similarly, binding of biomolecules to dendritic nanocarriers (e.g., protein corona) may be
observed by the changes of the fluorescence lifetime of the nanocarrier bound fluorophore [62].
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Figure 7. Relative amplitudes of the fluorescence anisotropy decay reflect on the conformational
flexibility of nanoparticles. This example shows the temperature dependent changes in conformational
flexibility of the CMS nanocarrier. (A) The relative amplitudes βi of the fluorescence anisotropy
decay CMS/NR reflect on the motional freedom of the dye, the conformational flexibility of the
nanocarrier branches and the overall steric restriction; (B) Schematic representation of the increase
of conformational space (indicated by the cone size) of NR as well as the increased flexibility of NC
branches with increasing temperature. (A, adapted with permission from Boreham et al. [61], © 2014
The American Chemical Society).
3.5. Conformational Transitions Affecting Drug Partitioning (Temperature Dependent Anisotropy, Temperature
Dependent Lifetime, Two-State Transitions)
Changes in the molecular structure of the nanocarrier can of course have direct consequences
on the distribution of guest molecules within the nanocarrier. Such changes may be induced by
altering the environment, e.g., temperature, for CMS nanocarriers. The use of both time-resolved
fluorescence lifetime and anisotropy measurements allows to simultaneously monitor the changes
in the distribution of a loaded fluorescent drug mimetic and the conformational flexibility of the
nanocarrier itself. A direct correlation between conformational changes and drug partitioning can
then be obtained. Depending on the transition behavior, appropriate models can be selected that
can further characterize the observed transition with regard to thermodynamic parameters, e.g.,
the transition temperature.
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Figure 8. Drug partitioning in CMS/NR as a function of temperature. (A) The ratio of the relative
amplitudes α2 and α3 reflects on the ratio of NR close to the surface and near the hydrophobic inner
shell of CMS. With increasing temperature NR partitioning is shifted in favor of surface vicinity.
The dashed green line indicates the transition temperature determined from a fit of the data with
a two-state transition model; (B) Schematic representation of the redistribution of NR within the
different shells (blue—hydrophilic, green—hydrophobic, grey—PG-core) of CMS occurring with
temperature. The number of incorporated dye molecules (approximately one per CMS structure) is
not drawn to scale but to visualize the distribution (adapted with permission from Boreham et al. [61],
© 2014 The American Chemical Society).
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In the case of NR loaded CMS nanocarriers it was shown from temperature dependent
fluorescence anisotropy measurements that temperature induced conformational transitions occur [61]
(Figure 7B). At the same time, the ratio of the fluorescence lifetimes reflecting on the NR partitioning
also exhibited a temperature dependent behavior, with more NR molecules near the CMS/water
interface at higher temperatures. Both transitions were approximated with a two-state transition
model [15,61,63,64] (Figures 7 and 8), revealing that the phase transition in the CMS nanocarrier branch
dynamics leads to a shift in the distribution of the encapsulated hydrophobic cargo molecule from the
CMS interior toward the outer shell/solvent interface at higher temperatures (Figure 8B).
4. From Molecular to Cellular/Tissue Insight
Understanding the behavior of a nanoparticle in vivo is of fundamental importance for the
application in nanomedicine. Biodistribution and metabolic clearance are both directly related to
cytotoxicity and biocompatibility of nanoparticles and biomolecules, while a deeper understanding
of the principles governing the behavior at interfaces as well as the transport of substances across
barriers is required for the rational design of new drug delivery vehicles. In this context biomolecular
interactions of the respective nanoparticle are of utmost importance. In the case of dPGS, the dendritic
nanoparticle was shown to be anti-inflammatory active through the binding of dPGS to selectins [26,30],
i.e., the interactions of dPGS in blood serum play a role. Using the unique fluorescence lifetime of
ICC bound to dPGS, time-resolved fluorescence lifetime experiments provided evidence that dPGS
recognizes L-selectin despite the presence of other competing proteins in blood plasma [62].
Fluorescence lifetime imaging microscopy (FLIM) can be used to spatially resolve fluorescent
molecules based on their fluorescence lifetime, gaining additional contrast compared to conventional
fluorescence microscopy. Furthermore, FLIM can help visualizing interaction processes with various
biomolecules, based on the changes in fluorescence lifetimes upon interaction. However, the poor
signal-to-noise ratios and high fluorescent backgrounds, e.g., common in FLIM imaging of skin and
tissue samples, are a challenge for FLIM data analysis [15].
4.1. Distinguishing Between Nanoparticles and Autofluorescence Using the Unique Fluorescence
Lifetime Signature
The unique fluorescence lifetime signature of fluorescently labeled nanoparticles can be used to
separate them from the background autofluorescence. Recently a number of publications by our group
have reported on successful detection of nanoparticles in tissue samples based on unique fluorescence
lifetime signatures [11–14,16,61]. A ratiometric FLIM approach [12] used the amplitude ratio of the two
fluorescence decay components in the fluorescence lifetime signature of the target molecule dPGS-ICC
to separate dPGS-ICC fluorescence from liver tissue autofluorescence (Figure 9A). Localization of
dPGS-ICC to Kupffer cells in the liver could thus be shown [12]. However, when attempting to detect
dPGS-ICC specifically within cell membranes based on the unique fluorescence lifetime signature
determined in a vesicular lipid membrane system, it was found that the ratiometric FLIM approach
is limited to target molecules with no more than two lifetime components [15]. Further studies of
our group made use of a multivariate pattern recognition method to partition the fluorescence decay
curves into classes. Application of this new FLIM data analysis method enabled the identification
of penetration of ICC labeled CMS into skin samples [11] and the localization of FITC labeled silica
nanoparticles in mouse tissue sections [13,14].
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stripped skin. The false color coding is based on the unique fluorescence lifetimes of CMS–ICC 
nanotransporters (cyan, red) or ICC (blue) in the different skin layers. (D), the fluorescence lifetime 
traces (as measured by TCSPC) of CMS–ICC nanotransporters and ICC in aqueous solution are 
shown. (E–G), The fluorescence lifetime traces of CMS–ICC nanotransporters and ICC are shown in 
the same colors as used in the corresponding overlay images (A–C). All lifetime traces are normalized 
to 1. Scale bar: 100 µm (reprinted from Alnasif et al. [11] with permission from Elsevier, © 2014). 
 
Figure 9. Examples of distinguishing of fluorescently labeled nanoparticles from tissue autofluorescence
using unique fluorescence lifetime signatures as measured by TCSPC in a FLIM setup. (A) Unique
fluorescence lifetime signature of dPGS-ICC. The lifetimes and relative amplitudes are given;
(B,C) Ratiometric FLIM analysis detecting dPGS-ICC in liver tissue. The specific lifetime amplitude
ratio for dPGS-ICC (red) was only observed in tissue samples containing dPGS-ICC (C) and not in the
control sample (B). Scale bar: 50 µm (Reprinted (adapted) from Boreham et al. [12] with permission of
The American Chemical Society, © 2011).
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4.2. Unique Fluorescence Lifetime Signature as a Tool to Detect Environmental Effects
As the fluorescence lifetime is a very sensitive tool for environmental changes, FLIM can also be
employed to detect environmental effects in tissue samples. If such environmental effects are restricted
to certain characteristic regions of a tissue sample, these may hint to specific interactions with proteins
or lipids. Hence, FLIM analysis methods capable of resolving these differences in the fluorescence
lifetime signatures are needed. Examples are the penetration of CMS-ICC (Figure 10) [11] or hyaluronic
acid [16] into skin samples with a normal or a deficient barrier. While CMS-ICC [11] in barrier deficient
skin and deeper layers of normal barrier skin all showed the same fluorescence lifetime signature,
a further CMS-ICC specific fluorescence lifetime signature was observed exclusively in the upper
skin layer, the stratum corneum, of normal barrier skin. These observed differences between the
fluorescence lifetime curves in stratum corneum and deeper skin layers indicate striking interactions
of the carrier with the lipids or proteins of the stratum corneum.
5. Conclusions
In conclusion, time-resolved fluorescence techniques are powerful tools at the interface between
chemical/material science and biological application for the new task presented by the emerging field
of nanomedicine. The application of time-resolved fluorescence spectroscopy and fluorescence lifetime
imaging (FLIM) for the analysis of nanoparticles allows to gain new insights, from the molecular
up to the tissue level. On a molecular level, the sensitivity of the fluorescence lifetime to changes
in a fluorophores environment facilitates analysis of the drug partitioning in nanocarriers while
measurements of the time-resolved fluorescence anisotropy can report on the successful binding
or loading of molecules to nanoparticles, on drug release, and also on the size and conformational
flexibility of nanoparticles. Environment specific unique fluorescence decay curves [62] of fluorescent
reporter groups attached to or loaded onto nanoparticles allow to distinguish reporter group
fluorescence from autofluorescence in cell and tissue samples [11–16]. This enables, for example,
investigating the biodistribution in tissue, skin penetration, and environmental effects in cells and
tissue. Moreover, when using the appropriate experimental approaches it is even possible to quantify
particle amounts and detect close interactions of labeled molecules.
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dPGS Dendritic polyglycerol sulfate
dPGS-ICC Indocarbocyanine bound to dendritic polyglycerol sulfate
FLIM Fluorescence lifetime imaging microscopy
FRET Förster resonance energy tranfer
ICC Indocarbocyanine
TCSPC Time-correlated single photon counting
References
1. Rizzo, L.Y.; Theek, B.; Storm, G.; Kiessling, F.; Lammers, T. Recent progress in nanomedicine: Therapeutic,
diagnostic and theranostic applications. Curr. Opin. Biotechnol. 2013, 24, 1159–1166. [CrossRef] [PubMed]
Molecules 2017, 22, 17 16 of 18
2. Thorley, A.J.; Tetley, T.D. New perspectives in nanomedicine. Pharmacol. Ther. 2013, 140, 176–185. [CrossRef]
[PubMed]
3. Moghimi, S.M.; Hunter, A.C.; Murray, J.C. Nanomedicine: Current status and future prospects. Faseb. J. 2005,
19, 311–330. [CrossRef] [PubMed]
4. Alexiev, U.; Farrens, D.L. Fluorescence spectroscopy of rhodopsins: Insights and approaches.
Biochim. Biophys. Acta 2014, 1837, 694–709. [CrossRef] [PubMed]
5. Gustafson, T.P.; Lim, Y.H.; Flores, J.A.; Heo, G.S.; Zhang, F.; Zhang, S.; Samarajeewa, S.; Raymond, J.E.;
Wooley, K.L. Holistic assessment of covalently labeled core-shell polymeric nanoparticles with fluorescent
contrast agents for theranostic applications. Langmuir 2014, 30, 631–641. [CrossRef] [PubMed]
6. Vogt, A.; Wischke, C.; Neffe, A.T.; Ma, N.; Alexiev, U.; Lendlein, A. Nanocarriers for drug delivery into and
through the skin—do existing technologies match clinical challenges? J. Control. Release 2016, 242, 3–15.
[CrossRef] [PubMed]
7. Festy, F.; Ameer-Beg, S.M.; Ng, T.; Suhling, K. Imaging proteins in vivo using fluorescence lifetime microscopy.
Mol. Biosyst. 2007, 3, 381–391. [CrossRef] [PubMed]
8. Dmitriev, R.I.; Papkovsky, D.B. Optical probes and techniques for O2 measurement in live cells and tissue.
Cell. Mol. Life Sci. 2012, 69, 2025–2039. [CrossRef] [PubMed]
9. Hille, C.; Berg, M.; Bressel, L.; Munzke, D.; Primus, P.; Lohmannsroben, H.G.; Dosche, C. Time-domain
fluorescence lifetime imaging for intracellular pH sensing in living tissues. Anal. Bioanal. Chem. 2008, 391,
1871–1879. [CrossRef] [PubMed]
10. Wolfbeis, O.S. An overview of nanoparticles commonly used in fluorescent bioimaging. Chem. Soc. Rev.
2015, 44, 4743–4768. [CrossRef] [PubMed]
11. Alnasif, N.; Zoschke, C.; Fleige, E.; Brodwolf, R.; Boreham, A.; Ruhl, E.; Eckl, K.M.; Merk, H.F.; Hennies, H.C.;
Alexiev, U.; et al. Penetration of normal, damaged and diseased skin—An in vitro study on dendritic
core-multishell nanotransporters. J. Control. Release 2014, 185, 45–50. [CrossRef] [PubMed]
12. Boreham, A.; Kim, T.Y.; Spahn, V.; Stein, C.; Mundhenk, L.; Gruber, A.D.; Haag, R.; Welker, P.; Licha, K.;
Alexiev, U. Exploiting Fluorescence Lifetime Plasticity in FLIM: Target Molecule Localization in Cells and
Tissues. ACS Med. Chem. Lett. 2011, 2, 724–728. [CrossRef] [PubMed]
13. Ostrowski, A.; Nordmeyer, D.; Boreham, A.; Brodwolf, R.; Mundhenk, L.; Fluhr, J.W.; Lademann, J.; Graf, C.;
Ruhl, E.; Alexiev, U.; Gruber, A.D. Skin barrier disruptions in tape stripped and allergic dermatitis models
have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles.
Nanomedicine 2014, 10, 1571–1581. [CrossRef] [PubMed]
14. Ostrowski, A.; Nordmeyer, D.; Boreham, A.; Holzhausen, C.; Mundhenk, L.; Graf, C.; Meinke, M.C.; Vogt, A.;
Hadam, S.; Lademann, J.; Ruhl, E.; Alexiev, U.; Gruber, A.D. Overview about the localization of nanoparticles
in tissue and cellular context by different imaging techniques. Beilstein J. Nanotech. 2015, 6, 263–280.
[CrossRef] [PubMed]
15. Boreham, A.; Brodwolf, R.; Pfaff, M.; Kim, T.-Y.; Schlieter, T.; Mundhenk, L.; Gruber, A.D.; Gröger, D.;
Licha, K.; Haag, R.; Alexiev, U. Temperature and environment dependent dynamic properties of a dendritic
polyglycerol sulfate. Polym Adv. Technol. 2014, 25, 1329–1336. [CrossRef]
16. Witting, M.; Boreham, A.; Brodwolf, R.; Vavrova, K.; Alexiev, U.; Friess, W.; Hedtrich, S. Interactions
of hyaluronic acid with the skin and implications for the dermal delivery of biomacromolecules.
Mol. Pharmaceutics 2015, 12, 1391–1401. [CrossRef] [PubMed]
17. Duncan, R.; Gaspar, R. Nanomedicine(s) under the Microscope. Mol. Pharmaceut 2011, 8, 2101–2141.
[CrossRef] [PubMed]
18. Kannan, R.M.; Nance, E.; Kannan, S.; Tomalia, D.A. Emerging concepts in dendrimer-based nanomedicine:
From design principles to clinical applications. J. Intern. Med. 2014, 276, 579–617. [CrossRef] [PubMed]
19. Tomalia, D.A. Special Issue: “Functional Dendrimers”. Molecules 2016, 21, 1035. [CrossRef] [PubMed]
20. Lukowiak, M.C.; Thota, B.N.; Haag, R. Dendritic core-shell systems as soft drug delivery nanocarriers.
Biotechnol. Adv. 2015, 33, 1327–1341. [CrossRef] [PubMed]
21. Lebedev, A.Y.; Cheprakov, A.V.; Sakadzic, S.; Boas, D.A.; Wilson, D.F.; Vinogradov, S.A. Dendritic
Phosphorescent Probes for Oxygen Imaging in Biological Systems. Acs. Appl. Mater. Inter. 2009, 1,
1292–1304. [CrossRef] [PubMed]
22. Fan, X.S.; Li, Z.B.A.; Loh, X.J. Recent development of unimolecular micelles as functional materials and
applications. Polym. Chem. 2016, 7, 5898–5919. [CrossRef]
Molecules 2017, 22, 17 17 of 18
23. Wang, D.L.; Zhao, T.Y.; Zhu, X.Y.; Yan, D.Y.; Wang, W.X. Bioapplications of hyperbranched polymers.
Chem Soc. Rev. 2015, 44, 4023–4071. [CrossRef] [PubMed]
24. Calderón, M.; Strumia, M. Hyperbranched and hiperfunctionalized materials from dendritic chemistry.
Rev. LatinAm Metal. Mater. 2013, 33, 2–14.
25. Khandare, J.; Calderon, M.; Dagia, N.M.; Haag, R. Multifunctional dendritic polymers in nanomedicine:
Opportunities and challenges. Chem. Soc. Rev. 2012, 41, 2824–2848. [CrossRef] [PubMed]
26. Dernedde, J.; Rausch, A.; Weinhart, M.; Enders, S.; Tauber, R.; Licha, K.; Schirner, M.; Zugel, U.; von Bonin, A.;
Haag, R. Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation. Proc. Natl. Acad. Sci. USA
2010, 107, 19679–19684. [CrossRef] [PubMed]
27. Quadir, M.A.; Radowski, M.R.; Kratz, F.; Licha, K.; Hauff, P.; Haag, R. Dendritic multishell architectures for
drug and dye transport. J. Control. Release 2008, 132, 289–294. [CrossRef] [PubMed]
28. Calderón, M.; Quadir, M.A.; Sharma, S.K.; Haag, R. Dendritic polyglycerols for biomedical applications.
Adv. Mater. 2010, 22, 190–218. [CrossRef] [PubMed]
29. Licha, K.; Welker, P.; Weinhart, M.; Wegner, N.; Kern, S.; Reichert, S.; Gemeinhardt, I.; Weissbach, C.; Ebert, B.;
Haag, R.; Schirner, M. Fluorescence imaging with multifunctional polyglycerol sulfates: novel polymeric
near-IR probes targeting inflammation. Bioconjug Chem. 2011, 22, 2453–2460. [CrossRef] [PubMed]
30. Papp, I.; Dernedde, J.; Enders, S.; Haag, R. Modular synthesis of multivalent glycoarchitectures and their
unique selectin binding behavior. Chem. Commun. 2008, 5851–5853. [CrossRef] [PubMed]
31. Weinhart, M.; Groger, D.; Enders, S.; Dernedde, J.; Haag, R. Synthesis of dendritic polyglycerol anions and
their efficiency toward L-selectin inhibition. Biomacromolecules 2011, 12, 2502–2511. [CrossRef] [PubMed]
32. Paulus, F.; Schulze, R.; Steinhilber, D.; Zieringer, M.; Steinke, I.; Welker, P.; Licha, K.; Wedepohl, S.;
Dernedde, J.; Haag, R. The effect of polyglycerol sulfate branching on inflammatory processes.
Macromol. Biosci. 2014, 14, 643–654. [CrossRef] [PubMed]
33. Tomalia, D.A.; Khanna, S.N. A Systematic Framework and Nanoperiodic Concept for Unifying Nanoscience:
Hard/Soft Nanoelements, Superatoms, Meta-Atoms, New Emerging Properties, Periodic Property Patterns,
and Predictive Mendeleev-like Nanoperiodic Tables. Chem. Rev. 2016, 116, 2705–2774. [CrossRef] [PubMed]
34. Fleige, E.; Ziem, B.; Grabolle, M.; Haag, R.; Resch-Genger, U. Aggregation Phenomena of Host and Guest
upon the Loading of Dendritic Core-Multishell Nanoparticles with Solvatochromic Dyes. Macromolecules
2012, 45, 9452–9459. [CrossRef]
35. Kuchler, S.; Radowski, M.R.; Blaschke, T.; Dathe, M.; Plendl, J.; Haag, R.; Schafer-Korting, M.; Kramer, K.D.
Nanoparticles for skin penetration enhancement—A comparison of a dendritic core-multishell-nanotransporter
and solid lipid nanoparticles. Eur. J. Pharm Biopharm. 2009, 71, 243–250. [CrossRef] [PubMed]
36. Radowski, M.R.; Shukla, A.; von Berlepsch, H.; Bottcher, C.; Pickaert, G.; Rehage, H.; Haag, R.
Supramolecular aggregates of dendritic multishell architectures as universal nanocarriers. Angew Chem. Int.
Ed. Engl. 2007, 46, 1265–1269. [CrossRef] [PubMed]
37. Turk, H.; Shukla, A.; Alves Rodrigues, P.C.; Rehage, H.; Haag, R. Water-soluble dendritic core-shell-type
architectures based on polyglycerol for solubilization of hydrophobic drugs. Chemistry 2007, 13, 4187–4196.
[CrossRef] [PubMed]
38. Wolf, N.B.; Kuchler, S.; Radowski, M.R.; Blaschke, T.; Kramer, K.D.; Weindl, G.; Kleuser, B.; Haag, R.;
Schafer-Korting, M. Influences of opioids and nanoparticles on in vitro wound healing models. Eur. J.
Pharm. Biopharm. 2009, 73, 34–42. [CrossRef] [PubMed]
39. Pischon, H.; Radbruch, M.; Ostrowski, A.; Volz, P.; Gerecke, C.; Unbehauen, M.; Hönzke, S.; Hedtrich, S.;
Fluhr, J.; Haag, R.; Kleuser, B.; Alexiev, U.; Gruber, A.; Mundhenk, L. Stratum corneum targeting by dendritic
core-multishell-nanocarriers in a mouse model of psoriasis. Nanomedicine 2016, 13, 317–327. [CrossRef]
[PubMed]
40. Hönzke, S.; Gerecke, C.; Elpelt, A.; Zhang, N.; Unbehauen, M.; Kral, V.; Fleige, E.; Paulus, F.; Haag, R.;
Schäfer-Korting, M.; Kleuser, B.; Hedtrich, S. Tailored dendritic core-multishell nanocarriers for efficient
dermal drug delivery: A systematic top-down approach from synthesis to preclinical testing. J. Control.
Release 2016, 242, 50–63. [CrossRef] [PubMed]
41. Kurniasih, I.N.; Keilitz, J.; Haag, R. Dendritic nanocarriers based on hyperbranched polymers. Chem. Soc. Rev.
2015, 44, 4145–4164. [CrossRef] [PubMed]
42. Hertzberg, R.P.; Pope, A.J. High-throughput screening: New technology for the 21st century. Curr. Opin.
Chem. Biol. 2000, 4, 445–451. [CrossRef]
Molecules 2017, 22, 17 18 of 18
43. Janzen, W.P. Screening Technologies for Small Molecule Discovery: The State of the Art. Chem. Biol. 2014, 21,
1162–1170. [CrossRef] [PubMed]
44. Owicki, J.C. Fluorescence polarization and anisotropy in high throughput screening: Perspectives and
primer. J. Biomol. Screen 2000, 5, 297–306. [CrossRef] [PubMed]
45. Sundberg, S.A. High-throughput and ultra-high-throughput screening: Solution- and cell-based approaches.
Curr. Opin. Biotechnol. 2000, 11, 47–53. [CrossRef]
46. Kellogg, R.E.; Bennett, R.G. Radiationless Intermolecular Energy Transfer. III. Determination of
Phosphorescence Efficiencies. J. Chem. Phys. 1964, 41, 3042–3045. [CrossRef]
47. Waggoner, A.; DeBiasio, R.; Conrad, P.; Bright, G.R.; Ernst, L.; Ryan, K.; Nederlof, M.; Taylor, D. Multiple
spectral parameter imaging. Methods Cell. Bio. 1989, 30, 449–478.
48. Eftink, M.R.; Ghiron, C.A. Fluorescence quenching studies with proteins. Anal. Biochem. 1981, 114, 199–227.
[CrossRef]
49. Lakowicz, J.R. Principles of Fluorescence Spectroscopy; Springer US: Boston, MA, USA, 2006.
50. Dexter, D.L. A Theory of Sensitized Luminescence in Solids. J. Chem. Phys. 1953, 21, 836–850. [CrossRef]
51. de Silva, A.P.; Moody, T.S.; Wright, G.D. Fluorescent PET (Photoinduced Electron Transfer) sensors as potent
analytical tools. Analyst 2009, 134, 2385–2393. [CrossRef] [PubMed]
52. Förster, T. Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann. Phys. 1948, 437, 55–75. [CrossRef]
53. Alexiev, U.; Rimke, I.; Pohlmann, T. Elucidation of the nature of the conformational changes of the
EF-interhelical loop in bacteriorhodopsin and of the helix VIII on the cytoplasmic surface of bovine rhodopsin:
A time-resolved fluorescence depolarization study. J. Mol. Biol. 2003, 328, 705–719. [CrossRef]
54. Kim, T.-Y.; Winkler, K.; Alexiev, U. Picosecond multidimensional fluorescence spectroscopy: A tool to
measure real-time protein dynamics during function. Photochem. Photobiol. 2007, 83, 378–384. [CrossRef]
[PubMed]
55. Munro, I.; McGinty, J.; Galletly, N.; Requejo-Isidro, J.; Lanigan, P.M.P.; Elson, D.S.; Dunsby, C.; Neil, M.A.A.;
Lever, M.J.; Stamp, G.W.H.; et al. Toward the clinical application of time-domain fluorescence lifetime
imaging. J. Biomed. Optics 2005, 10, 051403-9. [CrossRef] [PubMed]
56. König, K. Hybrid multiphoton multimodal tomography of in vivo human skin. IntraVital 2012, 1, 11–26.
[CrossRef]
57. Yew, E.; Rowlands, C.; So, P.T.C. Application of Multiphoton Microscopy in Dermatological Studies:
A Mini-Review. J. Innovative Opt. Health Sci. 2014, 7, 1330010. [CrossRef] [PubMed]
58. Hanson, K.M.; Behne, M.J.; Barry, N.P.; Mauro, T.M.; Gratton, E.; Clegg, R.M. Two-photon fluorescence
lifetime imaging of the skin stratum corneum pH gradient. Biophys. J. 2002, 83, 1682–1690. [CrossRef]
59. Kinosita, K., Jr.; Kawato, S.; Ikegami, A. A theory of fluorescence polarization decay in membranes. Biophys. J.
1977, 20, 289–305. [CrossRef]
60. Schröder, G.F.; Alexiev, U.; Grubmüller, H. Simulation of Fluorescence Anisotropy Experiments: Probing
Protein Dynamics. Biophys. J. 2005, 89, 3757–3770. [CrossRef] [PubMed]
61. Boreham, A.; Pfaff, M.; Fleige, E.; Haag, R.; Alexiev, U. Nanodynamics of dendritic core-multishell
nanocarriers. Langmuir 2014, 30, 1686–1695. [CrossRef] [PubMed]
62. Boreham, A.; Pikkemaat, J.; Volz, P.; Brodwolf, R.; Kuehne, C.; Licha, K.; Haag, R.; Dernedde, J.; Alexiev, U.
Detecting and Quantifying Biomolecular Interactions of a Dendritic Polyglycerol Sulfate Nanoparticle Using
Fluorescence Lifetime Measurements. Molecules 2016, 21, 22. [CrossRef] [PubMed]
63. Eftink, M.R. The use of fluorescence methods to monitor unfolding transitions in proteins. Biophys. J. 1994,
66, 482–501. [CrossRef]
64. Winkler, K.; Winter, A.; Rueckert, C.; Uchanska-Ziegler, B.; Alexiev, U. Natural MHC class I polymorphism
controls the pathway of peptide dissociation from HLA-B27 complexes. Biophys. J. 2007, 93, 2743–2755.
[CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
